First Time Loading...

Charles River Laboratories International Inc
NYSE:CRL

Watchlist Manager
Charles River Laboratories International Inc Logo
Charles River Laboratories International Inc
NYSE:CRL
Watchlist
Price: 235.93 USD 1.34%
Updated: May 15, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement
|
Revenue Breakdown

Balance Sheet

8.2B
-0.5%
Assets
Growth Rates:
1 Year
+6%
3 Years
+40%
5 Years
+108%
7 Years
+202%
10 Years
+394%
4.5B
-2%
Liabilities
Growth Rates:
1 Year
-2%
3 Years
+24%
5 Years
+78%
7 Years
+148%
10 Years
+372%
3.6B
+1%
Equity
Growth Rates:
1 Year
+17%
3 Years
+67%
5 Years
+160%
7 Years
+315%
10 Years
+423%

Balance Sheet Decomposition
Charles River Laboratories International Inc

8.2B
Assets
4.5B
Liabilities
8.2B
Assets
4.5B
Liabilities
Current Assets 1.7B
Cash & Short-Term Investments 337.1m
Receivables 787m
Other Current Assets 544.1m
Non-Current Assets 6.5B
Long-Term Investments 243.5m
PP&E 2B
Intangibles 3.9B
Other Non-Current Assets 340.1m
Current Liabilities 954.8m
Accounts Payable 129.7m
Accrued Liabilities 380.5m
Other Current Liabilities 444.6m
Non-Current Liabilities 3.6B
Long-Term Debt 2.7B
Other Non-Current Liabilities 897.1m

Balance Sheet
Charles River Laboratories International Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
160
118
118
164
195
238
228
241
234
277
Cash Equivalents
160
118
118
164
195
238
228
241
234
277
Short-Term Investments
0
0
4
29
1
1
1
1
1
0
Total Receivables
258
270
364
430
472
514
618
650
752
780
Accounts Receivables
258
270
364
430
472
514
618
643
752
780
Other Receivables
0
0
0
0
0
0
0
8
0
0
Inventory
89
94
96
115
128
161
186
199
256
380
Other Current Assets
72
78
76
89
101
108
168
182
196
171
Total Current Assets
579
559
657
827
898
1 021
1 201
1 274
1 439
1 609
PP&E Net
677
678
756
782
933
1 184
1 303
1 584
1 857
2 034
PP&E Gross
677
678
756
782
933
1 184
1 303
1 584
1 857
2 034
Accumulated Depreciation
655
645
706
801
874
978
1 086
1 103
1 161
1 335
Intangible Assets
179
281
394
370
611
689
788
1 061
955
864
Goodwill
321
439
788
805
1 247
1 541
1 809
2 712
2 850
3 095
Long-Term Investments
0
33
45
17
89
123
222
201
312
244
Other Long-Term Assets
115
79
72
130
79
134
169
192
190
350
Other Assets
321
439
788
805
1 247
1 541
1 809
2 712
2 850
3 095
Total Assets
1 871
N/A
2 069
+11%
2 712
+31%
2 930
+8%
3 856
+32%
4 693
+22%
5 491
+17%
7 024
+28%
7 603
+8%
8 195
+8%
Liabilities
Accounts Payable
34
37
69
78
66
112
123
198
206
169
Accrued Liabilities
139
162
178
191
244
318
381
508
463
496
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
32
17
27
31
31
39
50
3
4
6
Other Current Liabilities
90
96
156
164
216
242
286
324
419
385
Total Current Liabilities
295
312
430
464
558
710
840
1 033
1 092
1 055
Long-Term Debt
741
846
1 208
1 114
1 637
1 850
1 930
2 664
2 708
2 647
Deferred Income Tax
23
48
56
90
144
167
217
240
216
191
Minority Interest
32
33
17
19
21
32
29
57
47
62
Other Liabilities
108
97
165
199
179
299
361
496
565
642
Total Liabilities
1 198
N/A
1 335
+11%
1 875
+40%
1 885
+1%
2 539
+35%
3 058
+20%
3 376
+10%
4 489
+33%
4 626
+3%
4 598
-1%
Equity
Common Stock
1
1
1
1
1
1
1
1
1
1
Retained Earnings
139
11
165
289
42
280
625
981
1 433
1 887
Additional Paid In Capital
2 308
2 398
2 477
2 560
1 448
1 532
1 628
1 718
1 805
1 906
Treasury Stock
1 423
1 541
1 553
1 660
0
0
0
0
0
0
Other Equity
74
136
254
145
173
178
139
165
262
196
Total Equity
672
N/A
733
+9%
837
+14%
1 045
+25%
1 317
+26%
1 635
+24%
2 115
+29%
2 535
+20%
2 976
+17%
3 597
+21%
Total Liabilities & Equity
1 871
N/A
2 069
+11%
2 712
+31%
2 930
+8%
3 856
+32%
4 693
+22%
5 491
+17%
7 024
+28%
7 603
+8%
8 195
+8%
Shares Outstanding
Common Shares Outstanding
47
47
47
47
48
49
50
50
51
51

See Also

Summary
CRL intrinsic value, competitors valuation, and company profile.
DCF Valuation
CRL stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CRL stock valuation using valuation multiples.
Wall Street Estimates
CRL price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CRL stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 137,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.